Reimagining Therapeutic Formulations
We are resolving the complexity of therapeutics with nanotechnology and AI.
"ML Insights & Metrics is at the forefront of next-gen therapeutic delivery. We are reshaping how we look at medicine in the next 10 years."
nanoML
nanoML is our flagship analytics platform - leveraging AI to make nanoparticle data accessible.
Nanoparticles
Nanoparticles makes targeted delivery of therapeutics possible, making them safer and more effective
Drug Delivery Biology
Our expertise in drug delivery biology allow us to integrate nanoparticles and AI
AI & Computational Biophysics
Leverage generative AI to predict the most optimal therapy and nanoparticle combination
Our Story
Welcome to ML Insights & Metrics, where AI and big data meet to drive scientific advancements. We specialize in harnessing AI and machine learning to revolutionize nanoparticle drug formulation design and accelerate access to novel drug formulations.
Our mission is to break barriers that limit pharmaceutical advancements and increase accessibility to blockbuster drugs by leveraging the combined knowledge of the scientific community and AI to design nanoparticle formulations for targeted drug delivery.
We empower scientists with the tools and knowledge to streamline the development process, and test and validate their formulations in silico, and identify promising candidates that enhance therapeutic outcomes.
Join us on our journey to redefine nanoparticle formulation design and pioneer pharmaceutical innovation. Together, we can shape the future of healthcare by unlocking the potential of AI and machine learning to deliver safer and more effective treatments to improve lives globally.
Mission
Our vision is to empower scientists with an AI-augmented platform that enhances how they design, validate, and personalize therapeutic delivery with nanotechnology.
Accessible
Support due diligence and hypothesis generation based on empirical data
Safe
Derisk and accelerate formulation R&D from preclinical data
Effective
Develop and investigate optimal formulations for targeted therapeutic delivery
